Overview

Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This postmarketing surveillance study will evaluate the safety profile of Enbrel (etanercept) in an Indian population. It will provide surveillance on a currently approved indication for Enbrel of reducing symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Etanercept